This study is testing if adding two new drugs (Sintilimab and Peg-IFNα-2b) to a patient's current Hepatitis B medication can lead to a clinical cure. It involves 45 adults with stable Hepatitis B who meet specific blood test criteria. The main goal is to see if this combination c…
Phase: NA • Sponsor: Beijing 302 Hospital • Aim: ⭐️ CURE ⭐️
Last updated Mar 30, 2026 14:29 UTC